Surrey researchers Sign in
Rhizobium radiobacter Endophthalmitis following Intravitreal Ranibizumab Injection.
Journal article   Open access  Peer reviewed

Rhizobium radiobacter Endophthalmitis following Intravitreal Ranibizumab Injection.

L Joshi, J Morarji, O Tomkins-Netzer, S Lightman and SR Taylor
Case Rep Ophthalmol, Vol.3(3), pp.283-285
09/2012

Abstract

Endophthalmitis Gram-negative organism Intravitreal injection Rhizobium radiobacter Clinical Medicine
We present the first reported case of acute endophthalmitis due to Rhizobium radiobacter after an intravitreal injection of ranibizumab for neovascular age-related macular degeneration.
pdf
Rhizobium radiobacter Endophthalmitis following Intravitreal Ranibizumab Injection.723.16 kBDownloadView
TextSRIDA Open Access
url
http://www.ncbi.nlm.nih.gov/pubmed/23275789View
Author

Metrics

127 File views/ downloads
22 Record Views

Details

Usage Policy